Integral Health Asset Management, LLC Cytokinetics Inc Transaction History
Integral Health Asset Management, LLC
- $987 Million
- Q2 2025
A detailed history of Integral Health Asset Management, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 500,000 shares of CYTK stock, worth $17.2 Million. This represents 1.67% of its overall portfolio holdings.
Number of Shares
500,000
Previous 1,100,000
54.55%
Holding current value
$17.2 Million
Previous $44.2 Million
62.63%
% of portfolio
1.67%
Previous 5.14%
Shares
22 transactions
Others Institutions Holding CYTK
# of Institutions
368Shares Held
129MCall Options Held
3.62MPut Options Held
1.12M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$604 Million0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$503 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$411 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$269 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$219 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.23B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...